Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ERIC HO-YIN LEE

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1609211838
CMS profile
2782560
Location
FOUNTAIN VALLEY, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$23,645.10

370 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $6,367.48 29
PFIZER INC. $3,512.15 16
ADC Therapeutics America, Inc. $2,000.00 1
Genmab U.S., Inc. $1,822.83 4
Novartis Pharmaceuticals Corporation $1,681.77 37
SERVIER PHARMACEUTICALS LLC $1,582.66 6
Janssen Biotech, Inc. $535.53 24
Alexion Pharmaceuticals, Inc. $530.26 16
Merck Sharp & Dohme LLC $492.64 18
Takeda Pharmaceuticals U.S.A., Inc. $398.45 15
Eisai Inc. $291.98 12
Daiichi Sankyo Inc. $286.56 11
Exelixis Inc. $271.65 10
Gilead Sciences, Inc. $269.45 11
ABBVIE INC. $254.08 17
Incyte Corporation $245.15 9
GlaxoSmithKline, LLC. $210.88 10
Lilly USA, LLC $208.85 8
Astellas Pharma US Inc $186.70 7
Regeneron Healthcare Solutions, Inc. $176.04 6
E.R. Squibb & Sons, L.L.C. $166.33 16
BeiGene USA, Inc. $154.66 5
Kite Pharma, Inc. $128.09 4
Karyopharm Therapeutics Inc. $122.87 5
Boehringer Ingelheim Pharmaceuticals, Inc. $122.29 5
ARRAY BIOPHARMA INC $120.41 7
Genentech USA, Inc. $114.68 4
PUMA BIOTECHNOLOGY, INC. $110.85 4
Aveo Pharmaceuticals, Inc. $108.63 4
Coherus Biosciences Inc. $103.38 5
SpringWorks Therapeutics, Inc. $97.34 3
Rigel Pharmaceuticals, Inc. $92.08 4
Celgene Corporation $91.24 5
GENZYME CORPORATION $82.90 4
SANOFI-AVENTIS U.S. LLC $69.99 1
Stemline Therapeutics Inc. $69.06 2
Bayer Healthcare Pharmaceuticals Inc. $65.90 4
SOBI, INC $58.00 3
EMD Serono, Inc. $57.58 2
Ipsen Biopharmaceuticals, Inc $57.16 3
JAZZ PHARMACEUTICALS INC. $52.44 2
Boston Scientific Corporation $49.10 1
RECORDATI_RARE_DISEASES_INC. $45.10 2
TAIHO ONCOLOGY, INC. $40.16 2
TerSera Therapeutics LLC $34.36 1
PharmaEssentia USA Corporation $31.40 1
Geron Corporation $22.72 1
Fennec Pharmaceuticals, Inc. $22.66 1
Mirati Therapeutics, Inc. $16.44 1
Emmaus Medical, Inc. $12.17 1

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

370 matching records · $23,645.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 370 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 370.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Coherus Biosciences Inc. $21.9012/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261147276442 CMS
E.R. Squibb & Sons, L.L.C. $11.3112/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101355042 CMS
AstraZeneca Pharmaceuticals LP $15.3012/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104706861 CMS
Eisai Inc. $16.9112/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110744433 CMS
SERVIER PHARMACEUTICALS LLC $1,540.0012/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261147259486 CMS
Geron Corporation $22.7212/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261126533158 CMS
Boston Scientific Corporation $49.1012/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261092720738 CMS
Eisai Inc. $26.1412/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110744435 CMS
Exelixis Inc. $33.3812/17/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261138557635 CMS
Stemline Therapeutics Inc. $33.6612/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261142959660 CMS
E.R. Squibb & Sons, L.L.C. $15.3312/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101355036 CMS
E.R. Squibb & Sons, L.L.C. $0.1312/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101355038 CMS
GlaxoSmithKline, LLC. $20.4012/11/2024 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261155880039 CMS
AstraZeneca Pharmaceuticals LP $21.1812/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104735781 CMS
Novartis Pharmaceuticals Corporation $83.3312/10/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087152170 CMS
Eisai Inc. $21.3012/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110744437 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.8712/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261118077088 CMS
ABBVIE INC. $20.7412/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104151698 CMS
ABBVIE INC. $1.0012/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104151700 CMS
Alexion Pharmaceuticals, Inc. $26.4812/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261093963419 CMS
AstraZeneca Pharmaceuticals LP $27.4012/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261105537637 CMS
E.R. Squibb & Sons, L.L.C. $12.6611/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261101355030 CMS
ARRAY BIOPHARMA INC $24.0011/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131384084 CMS
Eisai Inc. $19.2711/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110744431 CMS
Exelixis Inc. $20.3311/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261138557629 CMS
Genentech USA, Inc. $30.9911/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133008257 CMS
Aveo Pharmaceuticals, Inc. $21.2711/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261143477243 CMS
Rigel Pharmaceuticals, Inc. $23.0211/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261145207621 CMS
AstraZeneca Pharmaceuticals LP $1,640.0011/19/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104577656 CMS
Novartis Pharmaceuticals Corporation $30.1611/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087152166 CMS
SpringWorks Therapeutics, Inc. $28.6711/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261085805907 CMS
Novartis Pharmaceuticals Corporation $83.3311/14/2024 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/20261086964780 CMS
PFIZER INC. $25.0611/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261131233109 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.8511/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261144961576 CMS
AstraZeneca Pharmaceuticals LP $22.1611/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104410413 CMS
Gilead Sciences, Inc. $24.6611/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261133805977 CMS
Janssen Biotech, Inc. $21.8811/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261078295505 CMS
Novartis Pharmaceuticals Corporation $30.7011/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261087152162 CMS
Alexion Pharmaceuticals, Inc. $34.4811/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261093971819 CMS
Eisai Inc. $29.2410/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261110744429 CMS
Astellas Pharma US Inc $29.0310/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139420903 CMS
Exelixis Inc. $27.8210/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261138557631 CMS
Coherus Biosciences Inc. $21.9010/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261147276434 CMS
Astellas Pharma US Inc $8.3510/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261139422185 CMS
AstraZeneca Pharmaceuticals LP $23.7810/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104600742 CMS
Daiichi Sankyo Inc. $29.9010/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261089447714 CMS
Incyte Corporation $28.7510/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141178902 CMS
JAZZ PHARMACEUTICALS INC. $28.3210/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261150222872 CMS
Merck Sharp & Dohme LLC $34.4710/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261141683383 CMS
AstraZeneca Pharmaceuticals LP $22.1010/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261104653693 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,624.31 77
PY2020 $10,154.86 260
PY2021 $10,637.54 342
PY2022 $9,330.69 404
PY2023 $21,513.62 356
PY2024 $23,645.10 370
PY2025 $27,248.00 368

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
ERIC HO-YIN LEE, NPI 1609211838. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1609211838.
APA 7
IndustryPayments. (2026). ERIC HO-YIN LEE, NPI 1609211838 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1609211838
Bluebook
ERIC HO-YIN LEE, NPI 1609211838, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1609211838.

Source: Centers for Medicare & Medicaid Services, Open Payments.